Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
Journal: 1995/February - Nature
ISSN: 0028-0836
Abstract:
Treatment of infected patients with ABT-538, an inhibitor of the protease of human immunodeficiency virus type 1 (HIV-1), causes plasma HIV-1 levels to decrease exponentially (mean half-life, 2.1 +/- 0.4 days) and CD4 lymphocyte counts to rise substantially. Minimum estimates of HIV-1 production and clearance and of CD4 lymphocyte turnover indicate that replication of HIV-1 in vivo is continuous and highly productive, driving the rapid turnover of CD4 lymphocytes.
Relations:
Citations
(1K+)
Clinical trials
(3)
Diseases
(1)
Conditions
(1)
Drugs
(1)
Chemicals
(2)
Organisms
(2)
Processes
(2)
Anatomy
(2)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.